Pharmaco-proteomic Platform to Evaluate Drug Interactions in Liver Transplant Patients

Last updated: November 7, 2024
Sponsor: Pontificia Universidad Catolica de Chile
Overall Status: Active - Recruiting

Phase

N/A

Condition

Liver Transplantation

Treatment

Multi-drug interaction

Clinical Study ID

NCT06682325
23I10401
  • Ages > 18
  • All Genders

Study Summary

The goal of this observational study is to enhance the ability to forecast kidney failure in liver transplant patients in the ICU under multidrug treatment by developing a computer platform that integrates mathematical models of drug interactions, proteomics, and clinical data. The main outcomes it aims to develop are:

  1. Design the multidrug web computing platform with available information on drug pair interactions (DDIs).

  2. Integrate the proteomic and clinical data of liver transplant patients into the IT platform.

  3. Implement the multidrug web platform to predict the clinical evolution of liver transplant patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Liver transplant patients undergoing surgery at UC Christus Hospital

Exclusion

Exclusion Criteria:

  • Patients on renal replacement therapy

  • Patients for whom no clinical or pharmacological registry is available

Study Design

Total Participants: 48
Treatment Group(s): 1
Primary Treatment: Multi-drug interaction
Phase:
Study Start date:
June 01, 2023
Estimated Completion Date:
May 05, 2025

Study Description

The aim of this project is to enhance the ability to forecast kidney failure for liver transplant patients in the ICU by developing a computer platform that integrates mathematical models of drug interactions, proteomics, and clinical data. This integrated platform enables the prediction of the development of AKI in patients who have undergone OLT. Through the integration of mathematical models, the platform captures complex interactions between multiple drugs and proteomics data from patients, contributing to an improved predictive capacity for AKI outcomes.

By leveraging proteomic insights, personalized therapeutic interventions can be devised, promoting safer and more effective treatments. This research seeks to empower medical professionals with comprehensive information to navigate the complex landscape of drug interactions and personalized treatment strategies, ultimately contributing to improved patient outcomes and healthcare practices in the realm of liver transplantation.

Connect with a study center

  • Hospital ClínicoUC-Christus

    Santiago, 8330024
    Chile

    Active - Recruiting

  • Pontificia Universidad Católica de Chile

    Santiago,
    Chile

    Site Not Available

  • Universidad de Valparaíso

    Valparaíso,
    Chile

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.